Circulating immunoreactive interleukin-6 in cystic fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 157, Issue 6 PART I, 1998, Pages 1764-1769

  Nixon, Lisette S ^a   Yung, Bernard ^a   Bell, Scott C ^a   Elborn, J Stuart ^a   Shale, Dennis J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; INTERLEUKIN 6; LEUKOCYTE ELASTASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; LUNG INFECTION; MALE; NEUTROPHIL; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SPUTUM ANALYSIS;

EID: 0031836026     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.157.6.9704086     Document Type: Article

References (35)

1. Elborn, J. S., and D. J. Shale. 1990. Pathogenesis of lung injury in cysticfibrosis. Thorax 45:970-973.
2. Kronborg, G., M. B. Hansen, M. Svenson, A. Fomsgaard, N. Höiby, and K. Bendtzen. 1993. Cytokines in sputum and serum from patients with cystic fibrosis and chronic Pseudomonas aernginosa infection as markers of destructive inflammation in the lungs. Pediatr. Pulmonol. 15:292-297.
3. Rayner, R. J., M. S. Wiseman, S. M. Cordon, D. Norman, E. J. Hiller, and D. J. Shale. 1991. Inflammatory markers in cystic fibrosis. Respir. Med. 85:139-145.
4. Norman, D., J. S. Elborn, S. M. Cordon, R. J. Rayner, M. S. Wiseman, E. J. Hiller, and D. J. Shale. 1991. Plasma tumour necrosis factor alpha in cystic fibrosis. Thorax 46:91-95.
5. Brown, M. A., W. J. Morgan, P. R. Finley, and P. Scuderi. 1991. Circulating levels of tumour necrosis factor and interleukin-1 in cystic fibrosis. Pediatr. Pulmonol 10:86-91.
6. 1-antiproteinase complex in cystic fibrosis. Am. Rev. Respir. Dis. 144:580-585.
7. Wilmott, R. W., J. T. Kassab, P. L. Kilian, W. R. Benjamin, S. D. Douglas, and R. E. Wood. 1990. Increased levels of interleukin-1 in bronchoalveolar washings from children with bacterial pulmonary infections. Am. Rev. Respir. Dis. 14:365-368.
8. Konstan, M. W., K. A. Hilliard, T. M. Norvell, and M. Berger. 1994. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am. J. Respir. Crit. Care Med. 150:448-454.
9. Khan, T. Z., J. S. Wagener, T. Bost, J. Martinez, F. J. Accurso, and D. W. H. Riches. 1995. Early pulmonary inflammation in infants with cystic fibrosis. Am. J. Respir. Crit. Care Med 151:1075-1082.
10. Bonfield, T. L., M. W. Konstan, P. Burfeind, J. R. Panuska, J. B. Hilliard, and M. Berger. 1995. Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 13:257-261.
11. Noah, T. L., H. R. Black, Pi-Wan Cheng, R. E. Wood, and M. W. Leigh. 1997. Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. J. Infect. Dis. 175:638-647.
12. Elborn, J. S., S. M. Cordon, P. Western, I. A. Macdonald, and D. J. Shale. 1993. Tumour necrosis factor-α, resting energy expenditure and cachexia in cystic fibrosis. Clin. Sci. 85:563-568.
13. Cohick, C. B., D. E. Furst, S. Quagliata, K. A. Corcoran, K. J. Steere, J. G. Yager, and H. B. Lindsley. 1994. Analysis of elevated serum interleukin-6 levels in rheumatoid arthritis: correlation with erythrocyte sedimentation rate or C-reactive protein. J. Lab. Clin. Med. 123:721-727.
14. Puren, A. J., C. Feldman, N. Savage, P. J. Becker, and C. Smith. 1995. Patterns of cytokine expression in community-acquired pneumonia. Chest 107:1342-1349.
15. Elborn, J. S., F. M. Delamere, S. C. Bell, and D. J. Shale. 1995. Can tumor necrosis factor-α (TNF-α) be reliably measured in blood. Pediatr. Pulmonol. 19:226-230.
16. Humbert, M., G. Monti, F. Brenot, O. Sitbon, A. Portier, L. Grangeot-Keros, P. Duroux, P. Galanud, G. Simonneau, and D. Emilie. 1995. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am. J. Respir. Crit. Care Med. 151:1628-1631.
17. Akira, S., and T. Kishimoto. 1992. IL-6 and NF-IL6 in acute phase response and viral infection. Imnmnol. Rev. 127:25-50.
18. Sweed, Y., P. Puri, and D. J. Reen. 1992. Early induction of IL-6 in infants undergoing major abdominal surgery. J. Pediatr. Surg. 27:1033-1037.
19. Friedland, J. S., Y. Suputtamongkal, D. G. Remick, W. Chaowagul, R. M. Strieter, S. L. Kunkel, N. J. White, and G. E. Griffin. 1992. Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection. Infect. Immun. 60: 2402-2408.
20. Yanagawa, H., S. Sone, Y. Takahashi, T. Haku, S. Yano, T. Shinohara, and T. Ogura. 1995. Serum levels of interleukin 6 in patients with lung cancer. Br. J. Cancer 71:1095-1098.
21. Aderka, D., J. Le, and J. Vilcek. 1989. IL-6 inhibits lipopolysaccharideinduced TNFα production in cultured human monocytes, U937 cells and mice. J. Immunol. 145:3517-3523.
22. Ulich, T. R., S. Yin, K. Guo, E. S. Yi, D. Remick, and J. del Castillo. 1991. Intratracheal injection of endotoxin and cytokines: II. Interleukin-6 and transforming growth factor beta inhibit acute inflammation. Am. J. Pathol. 138:1097-1101.
23. Hughes, F. J., and G. L. Howells. 1993. Interleukin-6 inhibits bone formation in vitro. Bone Min. 21:21-28.
24. Rochat, T., D. O. Slosman, C. Pichard, and D. C. Belli. 1994. Body composition analysis by dual-energy X-ray absorptiometry in adults with cystic fibrosis. Chest 106:800-805.
25. Butler, T., M. Ho, G. Acharya, M. Tiwari, and H. Gallati. 1993. Interleukin-6, gamma Interferon, and tumor necrosis factor receptors in typhoid fever related to outcome of antimicrobial therapy. Antimicrob. Agents Chemother. 37:2418-2421.
26. Torre, D., C. Zeroli, M. Giola, G. P. Fiori, L. Nespoli, A. Daverio, and T. Martegani. 1993. Acute-phase proteins and levels of interleukin 1, interleukin 6, tumor necrosis factor-α, and interleukin 8 in children with pertussis. Am. J. Dis. Chest. 147:27-29.
27. Sherry, B., and A. Cerami. 1988. Cachectin/tumour necrosis factor exerts endocrine, paracrine and autocrine control of inflammatory responses. Cell Biol. 107:1269-1277.
28. Borden, E. C., and P. Chin. 1994. Interleukin-6: a cytokine with potential diagnostic and therapeutic roles. J. Lab. Clin. Med. 123:824-829.
29. Tafuto, S., I. Silvestri, P. D. Andrea, D. Ronga, and G. Abate. 1994. Interleukin-6: biological features and clinical implications. J. Biol. Regul. Homeost. Agents 8:1-8.
30. Van der Poll, T., and H. P. Sauerwein. 1993. Tumour necrosis factor-α: its role in the metabolic response to sepsis. Clin. Sci. 84:247-256.
31. Espat, N. J., L. L. Moldawer, and E. M. Copeland. 1995. Cytokine mediated alterations in host metabolism prevent nutritional repletion in cachectic cancer patients. J. Surg. Oncol. 58:77-82.
32. Schols, A. M. W. J., P. B. Soeters, W. H. M. Saris, and E. F. M. Wouters. 1991. Energy balance in patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 143:1248-1252.
33. May, L. T., H. Viguet, J. S. Kenney, N. Ida, A. C. Allison, and P. B. Sehgal. 1992. High levels of complexed interleukin-6 in human blood. J. Biol. Chem. 267:19698-19715.
34. Dembic, Z., H. Loetscher, U. Gubler, Y. Pan, H. Lahm, R. Gentz, M. Brockhaus, and W. Lesslauer. 1990. Two human TNF receptors have similar extracellular, but distinct intracellular domain sequences. Cytokine 2:231-237.
35. Corey, M., F. J. McLaughlin, M. Williams, and H. Levinson. 1988. A comparison of survival, growth and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J. Clin. Epidemiol. 41:583-591.